{"name":"Public Health England","slug":"public-health-england","ticker":"","exchange":"","domain":"","description":"Public Health England (PHE) was an executive agency of the Department of Health and Social Care in England which began operating on 1 April 2013 to protect and improve health and wellbeing and reduce health inequalities. Its formation came as a result of the reorganisation of the National Health Service (NHS) in England outlined in the Health and Social Care Act 2012. It took on the role of the Health Protection Agency, the National Treatment Agency for Substance Misuse and a number of other health bodies. It was an executive agency of the Department of Health and Social Care, and a distinct delivery organisation with operational autonomy.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Men C conjugate","genericName":"Men C conjugate","slug":"men-c-conjugate","indication":"Other","status":"marketed"},{"name":"Men C conjugate vaccine","genericName":"Men C conjugate vaccine","slug":"men-c-conjugate-vaccine","indication":"Other","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Hib conjugate vaccine","genericName":"Hib conjugate vaccine","slug":"hib-conjugate-vaccine","indication":"Prevention of invasive Haemophilus influenzae type b disease (meningitis, epiglottitis, bacteremia, pneumonia)","status":"marketed"}]}],"pipeline":[{"name":"Hib conjugate vaccine","genericName":"Hib conjugate vaccine","slug":"hib-conjugate-vaccine","phase":"marketed","mechanism":"The Hib conjugate vaccine stimulates the immune system to produce antibodies against Haemophilus influenzae type b by conjugating the bacterial polysaccharide capsule to a protein carrier.","indications":["Prevention of invasive Haemophilus influenzae type b disease (meningitis, epiglottitis, bacteremia, pneumonia)","Routine childhood immunization"],"catalyst":""},{"name":"Men C conjugate","genericName":"Men C conjugate","slug":"men-c-conjugate","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Men C conjugate vaccine","genericName":"Men C conjugate vaccine","slug":"men-c-conjugate-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPbS1MSHd3a1pXeEY5M3N2RDRsSFlOa1BnTTJOdHlPc2VDT1VuekRvWnFCbXlKcDNzS29VM3ZyYTF6UGtBUWU4RXlvSHhWMXppUlhxSXBKQkRfQmJ3UFNoNnNIUFNuNDNkbzRWeWR2bVJXbER3R1ZBc1FiRmlPckxLai15LVh5QmdmZ1hmLW9zOXJsbExQX3ZZTXcyeWlfTDJkYnlLUEduNnB0YzhucVRpdFE4Vk1LSGtYSWM4bElIYlR5SzZDaFBDcHZjRlpjckIxYTFkRDU5bVZKdkhpWXFZUVVvT1V1MktwN1pWU1doRk5zRzF1dC1iRDZlZ0tVZw?oc=5","date":"2026-04-02","type":"deal","source":"GOV.UK","summary":"NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA - GOV.UK","headline":"NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partne","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPRU04ZFVYU01KT01VNzBhZl9GUzRQd1EzamdSNVE0WHAtZG1jQjltbVF1dUY1SjBhNkx3TmNlbEd5Rjd4UWFIOEduVWNxSXZ2YkZ4Z0pxUXYyM19PUHJkeHJpNHFnT25ORmlVQmRqT29MWXJFN2d0RXFuTkVzcHJuM3FWUm8yY3Nsb0VPLTdfNjVrQVZJemc?oc=5","date":"2026-03-18","type":"pipeline","source":"Community Pharmacy England","summary":"NHS England letter regarding outbreak of meningococcal disease - Community Pharmacy England","headline":"NHS England letter regarding outbreak of meningococcal disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9RSzV3NHB2ZXEwdm14eXdKT0FGbVJmbjdkemI3d19ScUladndHWmFCZGJhcWxKMmF4SVJCcklfdVU5SjlKV1ZEZUJwOWdiazZ0dDBrR3QzSXd1dDFJQ3gyd1duOWlnSGVvSHZtVg?oc=5","date":"2026-02-26","type":"pipeline","source":"IBISWorld","summary":"Weight Loss Drugs in the UK: Public Health Investment or Economic Risk? - IBISWorld","headline":"Weight Loss Drugs in the UK: Public Health Investment or Economic Risk?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOMUVYWFFIa1hGV2Fad1VyMnRILUU2WHhvT01xYkNvV2hPMmRNZkhPNUhYT3hEbzNBU05keldaajVxRmRBa25zbnZmUm9rcEpBZy1YZWRFdkFjRC1XUDV0ZTg5QkNLdTZpcFFxWTdFRUZ3eGFEY0x5Z1ZxRzh2aFNwRkppQQ?oc=5","date":"2026-02-04","type":"deal","source":"pharmaphorum","summary":"Fears US drug pricing deal will weigh heavy on the NHS - pharmaphorum","headline":"Fears US drug pricing deal will weigh heavy on the NHS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPTUZKSmU2VlQyS1hWcm1XLUppSVlqZ2xVOWpvOGl3dXhwbEJlUTBubmVnS20xSHBsU0VCdVB4Z2RIOFhGQjNHQ1ctQ2Q2bk5iSzBUVFI4b1Y0RkV6elhNVFRzd0cxU0lXc3IwRVF2Q1FVMGpMS1Z2TlBfbzRzR29iaWRUQnlxV29KWTh1OV93TUtxeXNza3J0MGowenJKME9KNl9WVWxHcXVKLUtqM1QzTmMtZGpzNXRMenZTT1EtSlQ1ZWw3V0FpejV6c3hGb21nelVNZ1dKdmlKQXc3WnhoQ1V4UjZBRGNXdUY5VG52cmtpeEhuMF83aFMwV2Q0TERqakVfSW5B?oc=5","date":"2026-02-04","type":"deal","source":"UK Parliament","summary":"Costs of UK-US Pharma Deal will be met by DHSC, Science Minister confirms - UK Parliament","headline":"Costs of UK-US Pharma Deal will be met by DHSC, Science Minister confirms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPNE4zdHlBQUJxN3Z5N0pxR2c2a01rRmpFd3hwRmhhbjJJMlJHU1VHV242YXNSbjJCd2RNa1A2cU1KRi1aTzZQVmVRZEJicXZWSmEzNWtjMG1TUUhRaE42V04tcDNQZi1USWM5dEJFREtYSmNKblB6VV9Da0lVUWxKVXZlaXFmNUF2WWlCdXI0Y1o2Z1prcnlkc0xteVVMTmRvZ0tCcDdZbGJrUkVEM0FsZA?oc=5","date":"2026-02-04","type":"deal","source":"NHS Confederation","summary":"NHS Confederation comments on announcement that costs of UK–US pharma deal will be met by DHSC - NHS Confederation","headline":"NHS Confederation comments on announcement that costs of UK–US pharma deal will be met by DHSC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQQW1ZNWFTRlUwOFUxd09yNW1LSHljU3hmQmFsWXF4SEVROGlyY1UyVWtNZnUzM0VYOUJmeHU5WXBsaVVEM1EtUFY0QV9ZRTJQeFJGcG56MDhNOTNzZ2ZlNS1fekp0WkVHNHVJSUNPc25zTnN3UXhtMlRKb0g5WENsMDNVSDJMcm5qd2RwYW9RVkEzMTFpUDgzSWxKUEZtZnZ4WEV1TlZGM1pKUlFsT1FjM3FIcjRpNHZicGYtdEpR?oc=5","date":"2026-01-23","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Everything you need to know about PrEP provision in community pharmacy - The Pharmaceutical Journal","headline":"Everything you need to know about PrEP provision in community pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNZXM5ZmJ6TjZVa2t5X1BRUlRMSVctQ2hzUGN3czBzMXZQNzlvY293M3J2WmhkWl8ySzA0bGM0UkRTTDZhdWNReDFhUVljS1NBYmhwZUw5YUtUTWViN0RIUmVib3ZLRGJhWlQtSjh6aTlJZ0ZFVEhxeTZpa25RRlhZbVcxZkhNTG1DNHp1V0l2RnY2Zw?oc=5","date":"2025-12-16","type":"earnings","source":"Peoples Dispatch","summary":"US–UK pharma deal sacrifices patients for profit - Peoples Dispatch","headline":"US–UK pharma deal sacrifices patients for profit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxONnFocE5tc1Q5TFNTYWJ6U0JPcUlQVDU4UjhBX3ZaVTMtaExPQi1qNVFqY2RXQXVtd1Y2SGNGdm81bTcwQzlqTEp1MzBwMjlNekpkcWtWVlo2OFAwNDJxNWk2eVRKcUxqZEJfcGVUSmFlV0drWUpOR0FBcFI4STB0elY2bjhjSzFUYktiRjZhMDVYcUdzS1BxQmZBNUVYY2xHN185d3VLVVg5NTJGdENZZ0Y4Wm4zQm9CRXp0Um5TVkdFRnRlQWN4STBSRXA?oc=5","date":"2025-12-11","type":"deal","source":"Global Justice Now","summary":"NHS pharma deal a “catastrophe” for all NHS patients, over 200 health and economic experts state - Global Justice Now","headline":"NHS pharma deal a “catastrophe” for all NHS patients, over 200 health and economic experts state","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQYUFneG1HUnNPQWNFM29kc0R1VVZyN3l1QlhRazlMN1RZWVJzV1dNbHpQbzFsUmxSUDdaT1ZINEtYVG52TkdaMXVIcnNWSVNtQTRPTk1uc2M5TUM4OFF1R0ZqQnZ6QW52RjRVSTFZMjZKUm9oZDJJTC1oel9KUXJFZHVn?oc=5","date":"2025-12-01","type":"regulatory","source":"The New York Times","summary":"To Avoid Tariffs, U.K. Agrees to Trump’s Demand to Pay More for Drugs - The New York Times","headline":"To Avoid Tariffs, U.K. Agrees to Trump’s Demand to Pay More for Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNZl9jNjg3WXdaWGY3SUlMQkdTLUNKdFhSa2d0ZG16V0NIOWs0T2dmcTZLUXZLUmthLUppdVppTE41SllWclE1WVl2Wkl2LTJjeDJiTGFMeDhfVjVlaGNrUWxjX2VKVDJLUkxrUXZDMWR5M0dTVGdiZ2RvVjJFQlRLY3NWV0ZNTDFpd2JoemhxT21rTF9uQnN6VQ?oc=5","date":"2025-12-01","type":"deal","source":"The Guardian","summary":"NHS to pay 25% more for innovative drugs after UK–US zero-tariff deal - The Guardian","headline":"NHS to pay 25% more for innovative drugs after UK–US zero-tariff deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPMkRRYWNzUTlzbzB5WDdhcXc2UTVGUGRJWHhrNkR2eS1Yam9jZ3lPelJiLWc2SV9qYlFianRGN2Nva1VRUUZMRTdzNjhDemVxbHZ4dFlQMDhSRmN2UkV0MUYtNFhWZ181bDhIdDNQWlZvZEZuUWJ0cDlKX2RubTk2YnhIT2I1Y0lvSHJPR1V4Sm85R1lzZnBxU3BaNXFockpGckNRVTVValBJUnpabGdHRS1YdDJzeHpEeG11R2Z0MTJQMHFGQ28yYWc5YlVRbDg?oc=5","date":"2025-11-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Raising the bar: can higher drug spending in the UK deliver for pharma and patients? - Pharmaceutical Technology","headline":"Raising the bar: can higher drug spending in the UK deliver for pharma and patients?","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}